Mirion Technologies Inc. (NYSE: MIR) is a leading global provider of radiation detection, measurement and monitoring solutions. The company’s portfolio includes instrumentation, software and service offerings designed to detect, quantify and manage radiation in nuclear power, oil and gas, defense and homeland security, medical imaging and diagnostic applications. Mirion’s product suite spans personal and environmental dosimetry, area monitors, digital imaging detectors and turnkey solutions for decommissioning and environmental remediation projects.
Mirion traces its origins to the combination of several established radiation measurement businesses, including the former Canberra nuclear instrumentation division, and has been supported by private equity investors before completing its initial public offering on the New York Stock Exchange in 2023. The company conducts research and development, manufacturing and calibration activities at facilities across North America, Europe and Asia, delivering solutions to customers in more than 50 countries. A global service network offers on-site support, training and repair services to ensure regulatory compliance and operational continuity.
Under the leadership of Chief Executive Officer Philippe Samyn, Mirion has pursued a strategy focused on innovation, digitalization and strategic acquisitions to expand its technology platform and address emerging market needs. The executive team also includes Chief Financial Officer Andrew Bell and a board of directors with extensive experience in industrial instrumentation and investment management. Mirion continues to invest in next-generation detection technologies, software analytics and lifecycle services to strengthen its position in the growing global radiation safety and measurement market.